OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors
2023-11-24 10:00
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
You Might Like...
Reza Rassool Named Business Wire’s Chief Technology Officer, Focused on Innovation and Client Experience
Corporate ESG Claims to Soon Face Audits to Address Greenwashing Fears
NASA Selects Blue Origin for Astronaut Mission to the Moon
Athens Wildfires Threaten More Homes as Wind Seen Strengthening
There's a New King in Chip ETFs After Record $805 Million Inflow
South Korea launches homegrown rocket after delay
AI Firm Cohere Raises $270 Million With Oracle, Nvidia Backing
Factbox-Why does the US want to ban TikTok? The allegations against it